Benjamin J. Hindson
Title: President and Chief Scientific Officer, Director · 10x Genomics, Inc.
- 2024
- Aug 26, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Benjamin J. Hindson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Serge Saxonov - $6.82M in TXG purchases and sales in the last 12 months
- Adam Taich - $4.84M in TXG purchases and sales in the last 12 months
- John R. Stuelpnagel - $2.39M in TXG purchases and sales in the last 12 months
- Shehnaaz Suliman - $792K in TXG purchases and sales in the last 12 months
- Sarah A. Teichmann - $579K in TXG purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Benjamin J. Hindson?
Benjamin J. Hindson is a corporate insider, tracked as Title: President and Chief Scientific Officer, Director of 10x Genomics, Inc. (TXG). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Benjamin J. Hindson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Benjamin J. Hindson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($1.64M) across all tracked filings.
